Protai

Proteomics & AI Drug Discovery

Tel Aviv, Israel · Founded 2021

Headquarters
Tel Aviv
Employees
11–50
Founded
2021
Business Model
B2B
Website
protai.bio
Last Round
SeedMar 2023
Rounds
2

About

Founded in 2021 by CEO Eran Seger and CTO Kirill Pevzner, Protai is an Israeli biotech company headquartered in Tel Aviv. The company has built an end-to-end AI platform that comprehensively maps disease progression at the protein level, combining structural and functional proteomics with machine learning to identify up to 1 million proteoforms. Protai raised an $8M seed round to develop its proteomics-based drug discovery platform, and uses advanced protein simulations to discover novel medicines for cancer and other complex diseases. The company leverages AlphaFold and NVIDIA NIM for complex structure prediction.

Summary

Protai is an Artificial Intelligence company based in Tel Aviv, Israel, founded in 2021. Its most recent funding was a Seed round in Mar 2023. Investors include Grove Ventures, Pitango Growth and Maj Invest.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2023

Sign up to see all 2 rounds

Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Protai on Indexed.vc
<a href="https://indexed.vc/companies/protai"><img src="https://indexed.vc/api/badge/company/protai" alt="Protai on Indexed.vc" width="260" height="76" /></a>